As treatment time increased, the levels of lignin increased continuously
Iepsen EW, Have CT, Veedfald S, et al
Regarding medication management, for patients with clinical cardiovascular disease, a sodiumglucose cotransporter-2 (SGLT2) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist with proven cardiovascular benefit is recommended
Lancet 330(8571):13001304 Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B et al (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5
Furthermore, tirzepatide increased the levels of miR-212 and miR-29c, microRNAs that regulate gene expression linked to neuronal survival and function